Safer opioid supply programs have been the topic for much debate over the years. Today, our evaluation of London, Ontario’s SOS Program was released ➡️ cmaj.ca/content/194/36… 1/n We used linked admin. healthcare data to study patterns of healthcare contact in the 5 years before & 1 year after entering the SOS program. Primary outcomes incl. ED visits, inpatient hospitalizations, new infections and healthcare costs (excl. primary care and medication $) 2/n

During the pandemic, guidance for #OAT was modified around the world, leading to more flexible access to take-home doses for many people treated with #methadone and #buprenorphine. In our new study in @JAMA_current, we evaluated the impact of these changes on patient outcomes. We looked separately at ppl treated with #methadone and #buprenorphine, stratified by level of take-home doses before the pandemic (daily or weekly). We then examined how more flexible take-home doses were associated with risk of OAT discontinuation, interruption and #overdose.

New data on #OpioidDeaths in #Ontario released from the Coroner's Office today. Again, opioid-related deaths continue to climb, with 246 deaths in March 2021 (probable/confirmed) As we started to see in last month's release, carfentanil involvement continues to grow, contributing to 29 deaths in the first three months of 2021.

My mum was vaccinated at Toronto Congress Centre today. We were all excited and relieved; but I have been horrified to hear about her experience. I’m now fearful that today she was put at a higher risk of being exposed to #COVID19 than at any other point in this pandemic. 1/n Her appointment was for about 3pm. When she arrived, this was the length of line.
I expected there might be long lines outside...at least it was a beautiful day! ☀️2/n